Jones Financial Companies
CLSD

Jones Financial Companies’s Clearside Biomedical CLSD Stock Holding History

Jones Financial Companies’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-67
Closed -$1.16K – 3429
2024
Q3 		$1.16K Buy
+67
New +$1.14K ﹤0.01% 2784

Other funds holding CLSD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jones Financial Companies's CLSD Position: Q4 2024 in Review

Jones Financial Companies sold out of Clearside Biomedical (CLSD) in Q4 2024, closing a stake of 67 shares — an estimated $1.16K sold.

Jones Financial Companies first reported a position in CLSD in Q3 2024 and held it in 1 quarter. The position peaked at $1.16K in Q3 2024. 43 funds tracked by Wall St. Rank hold CLSD as of Q4 2024.

  • Jones Financial Companies reported no remaining Clearside Biomedical position as of Q4 2024 after selling out during the quarter.
  • Jones Financial Companies sold 67 Clearside Biomedical shares in Q4 2024, an estimated $1.16K.
  • Jones Financial Companies first reported a position in Clearside Biomedical in Q3 2024 and held it in 1 quarter.
  • Jones Financial Companies's Clearside Biomedical position peaked at $1.16K in Q3 2024.
  • 43 funds tracked by Wall St. Rank held Clearside Biomedical as of Q4 2024.

Based on Jones Financial Companies's 13F filing for Q4 2024, filed 6 Feb 2025.